The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.

Source:http://linkedlifedata.com/resource/pubmed/id/10696088

Download in:

View as

Triples

General Info

PMID
10696088